Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 60/100

Penumbra, Inc. to Present at Upcoming Investor Conferences Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and...

Key Takeaway: Penumbra, Inc. (NYSE: PEN) has announced that its management team will present at several upcoming investor conferences, including the William Blair Annual Growth Stock Conference and the Jefferies Global Healthcare Conference. These presentations will provide an opportunity for the company to showcase its innovations in thrombectomy technology. Webcasts of the presentations will be accessible on the company’s website for at least two weeks after each event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Management team scheduled to present at multiple notable investor conferences.
  • Opportunity for increased visibility and engagement with investors.
  • Focus on innovative technologies in the thrombectomy space.

Full Press Release Details

ALAMEDA, Calif. , May 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below.
Event: William Blair 45 th Annual Growth Stock Conference
Date: Tuesday, June 3, 2025
Time: 3:00pm ET/12:00pm PT
Event: Jefferies Global Healthcare Conference
Date: Wednesday, June 4, 2025
Time: 9:55am ET/6:55am PT
Event: Truist Securities MedTech Conference
Date: Tuesday, June 17, 2025
Time: 10:00am ET/7:00am PT
Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com . The webcasts will be available on the company's website for at least two weeks following each event.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations
[email protected]
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

What is Penumbra, Inc. known for?

Penumbra, Inc. is recognized as a leading thrombectomy company focused on innovative technologies.

When is the William Blair Conference presentation?

The William Blair Conference presentation is scheduled for June 3, 2025, at 3:00 PM ET.

How can I access Penumbra's investor presentations?

Webcasts of presentations can be accessed under the 'Events and Presentations' section on their website.

What is the focus of Penumbra's technology innovations?

Their innovations aim to improve treatment for conditions like ischemic stroke and venous thromboembolism.

When is the Truist Securities MedTech Conference?

The Truist Securities MedTech Conference will take place on June 17, 2025, at 10:00 AM ET.

Last updated: May 20, 2025